MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A novel G413S mutation in the CSF1R gene causes Hereditary Diffuse Leucoencephalopathy with axonal Spheroids; clinically overlapping features of Parkinsonism

    ANW. Ullah, MZB. Badshah (Peshawar, Nepal)

    Objective: The current study was designed to investigate the genetic cause of atypical Parkinsonism is a multigenerational Pakistani family Background: Hereditary Diffuse Leucoencephalopathy with axonal…
  • 2024 International Congress

    OPTN gene associated with corticobasal syndrome: a novel multi-exon deletion and literature review

    G. Bonato, M. Ginevrino, B. Savini, D. Ciprietti, P. Santurelli, E. Gasparoli, C. Gabelli, G. Sorarù, R. Biundo, M. Carecchio, A. Guerra, L. Salviati, A. Antonini (Padova, Italy)

    Objective: To describe a novel case of OPTN multiexon deletion causing a peculiar CBS-ALS phenotype. Background: While traditionally classified as distinct clinical entities, corticobasal syndrome…
  • 2024 International Congress

    Association of polygenic risk score of the LRRK2 gene for Parkinson’s disease with lysosomal hydrolase activities in the Russian Population based on genetic profile and established risk factors

    T. Usenko, K. Basharova, A. Bezrukova, K. Senkevich, I. Miliukhina, A. Timofeeva, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: To studied a previously proposed polygenic risk scores (PRSs) for PD selected for the LRRK2 gene in a genetic data set of Russian population…
  • 2024 International Congress

    Genetic Study of polymorphism of cytokines in Parkinson’s disease.

    S. Frikha, O. Ben Othmen, S. Fezai, A. Achouri, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The aim of our study was to conduct a cohort that demonstrates genetic variations in cytokines genes involved in the physiopathology, the development and…
  • 2024 International Congress

    Comorbidities in genetic Parkinson’s Disease: comparison between LRRK2, GBA1, and non-mutated PD

    G. Di Rauso, F. Pirone, G. Franco, F. Arienti, I. Trezzi, E. Frattini, F. Cavallieri, V. Rispoli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)

    Objective: To examine the occurrence of medical comorbidities associated with genetic form of Parkinson’s disease (GBA1-PD and LRRK2-PD) compared to a cohort of non-mutated PD…
  • 2024 International Congress

    Expanding the PD GENEration Study to increase clinical genetic testing and counseling using whole genome sequencing among diverse Parkinson’s disease (PD) populations

    K. Ghosh Galvelis, A. Naito, M. Dini, S. Rao, R. Deleon, A. Coral-Zambrano, T. Foroud, P. Hodges, L. Heathers, J. Verbrugge, L. Cook, J. Schulze, M. Totten, A. Hall, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, P. Ponger, J. Beck, R. Alcalay (New York, USA)

    Objective: To provide Clinical Laboratory Improvement Amendments (CLIA) genetic testing using whole genome sequencing and disclosure of 7 PD relevant genes and secondary health-related genetic…
  • 2024 International Congress

    Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease

    S. Jo, J-H. Oh, J. Lee, S. Son, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aim to conduct a genome-wide survival study (GWSS) to identify single nucleotide polymorphisms (SNP) associated with dementia in Parkinson’s disease (PD) with a…
  • 2024 International Congress

    A Patient with Overlapping SPG7 mutation and MERRF

    J. Patino, M. Koenig (Houston, USA)

    Objective: To describe the first case of concomitant spastic paraplegia type 7 (SPG7) and myoclonic epilepsy with ragged red fibers (MERRF) in a patient with…
  • 2024 International Congress

    Autosomal Recessive GTPCH Deficiency: Redefining the Phenotypic Spectrum and Outcome

    M. Novelli, M. Tolve, V. Quiroz, C. Carducci, R. Bove, G. Ricciardi, C. Yang, F. Pisani, D. Ebrahimi-Fakhari, S. Galosi, V. Leuzzi (Rome, Italy)

    Objective: To describe the clinical phenotype of autosomal recessive GTP cyclohydrolase deficiency (ARGTPCHD), its genetic and metabolic correlates, and their possible predictive value through a…
  • 2024 International Congress

    Ionic Plasticity of Midbrain GABAergic Synapses in PD Models

    A. Borgkvist, E. Bezard, M. Molinari, E. Santini, M. Canron (Solna, Sweden)

    Objective: To validate that enhancing potassium-chloride cotransporter activity would restore inhibition and normal function in parkinsonian Substantia nigra reticulata (SNr) and participate to Parkinson’s disease (PD) symptom alleviation. Background: The SNr is an output nucleus…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley